Decatur Capital Management buys $17,503,767 stake in Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) : Decatur Capital Management scooped up 20,175 additional shares in Intuitive Surgical during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 25,334 shares of Intuitive Surgical which is valued at $17,503,767.Intuitive Surgical makes up approximately 2.26% of Decatur Capital Management’s portfolio.

Other Hedge Funds, Including , Azimuth Capital Management added ISRG to its portfolio by purchasing 4,933 company shares during the most recent quarter which is valued at $3,408,308. Intuitive Surgical makes up approx 0.30% of Azimuth Capital Management’s portfolio.Stephens Inc Ar boosted its stake in ISRG in the latest quarter, The investment management firm added 3 additional shares and now holds a total of 144 shares of Intuitive Surgical which is valued at $99,840. Conestoga Capital Advisors sold out all of its stake in ISRG during the most recent quarter. The investment firm sold 335 shares of ISRG which is valued $230,939.

Intuitive Surgical opened for trading at $695 and hit $698.99 on the upside on Tuesday, eventually ending the session at $695.96, with a gain of 0.54% or 3.71 points. The heightened volatility saw the trading volume jump to 2,06,778 shares. Company has a market cap of $26,790 M.

On the company’s financial health, Intuitive Surgical reported $5.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.63 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $4.99. The company had revenue of $670.10 million for the quarter, compared to analysts expectations of $642.46 million. The company’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.57 EPS.

Many Wall Street Analysts have commented on Intuitive Surgical. Northland Capital Downgraded Intuitive Surgical on Jul 21, 2016 to ” Under Perform”, Price Target of the shares are set at $600.Company shares were Reiterated by Wedbush on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 755 from a previous price target of $715 .Company shares were Reiterated by Canaccord Genuity on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 750 from a previous price target of $700 .

Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.

Leave a Reply

Intuitive Surgical - Is it time to Sell?

Top Brokerage Firms are advising their investors on Intuitive Surgical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.